NDC 11673-819 – Naproxen Sodium and Diphenhydramine HCL
Diphenhydramine Hydrochloride 25 mg/1; Naproxen Sodium 220 mg/1 · Tablet · Oral
Product NDC11673-819
Product details
- Brand name
- Naproxen Sodium and Diphenhydramine HCL
- Generic name
- Naproxen Sodium and Diphenhydramine HCL
- Labeler
- TARGET CORPORATION
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA213663
- Marketed since
- March 1, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-1 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug
Active ingredients
- Diphenhydramine Hydrochloride 25 mg/1
- Naproxen Sodium 220 mg/1
Uses, dosage, side effects and warnings for Naproxen Sodium and Diphenhydramine HCl →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 11673-819-08 | 80 TABLET in 1 BOTTLE (11673-819-08) | Mar 1, 2024 |
Other Naproxen Sodium and Diphenhydramine HCl products
- 69238-1422 Naproxen Sodium 220 mg/1; Diphenhydramine Hydrochloride 25 mg/1 · Tablet, Film Coated · Amneal Pharmaceuticals NY LLC
- 62207-814 Naproxen Sodium 220 mg/1; Diphenhydramine Hydrochloride 25 mg/1 · Tablet, Film Coated · Granules India Ltd